ER/Golgi trafficking is facilitated by unbranched actin filaments containing Tpm4.2

Cytoskeleton (Hoboken). 2017 Oct;74(10):379-389. doi: 10.1002/cm.21405. Epub 2017 Aug 31.

Abstract

We have identified novel actin filaments defined by tropomyosin Tpm4.2 at the ER. EM analysis of mouse embryo fibroblasts (MEFs) isolated from mice expressing a mutant Tpm4.2 (Tpm4Plt53/Plt53 ), incapable of incorporating into actin filaments, revealed swollen ER structures compared with wild-type (WT) MEFs (Tpm4+/+ ). ER-to-Golgi, but not Golgi-to-ER trafficking was altered in the Tpm4Plt53/Plt53 MEFs following the transfection of the temperature sensitive ER-associated ts045-VSVg construct. Exogenous Tpm4.2 was able to rescue the ER-to-Golgi trafficking defect in the Tpm4Plt53/Plt53 cells. The treatment of WT MEFs with the myosin II inhibitor, blebbistatin, blocked the Tpm4.2-dependent ER-to-Golgi trafficking. The lack of an effect on ER-to-Golgi trafficking following treatment of MEFs with CK666 indicates that branched Arp2/3-containing actin filaments are not involved in anterograde vesicle trafficking. We propose that unbranched, Tpm4.2-containing filaments have an important role in maintaining ER/Golgi structure and that these structures, in conjunction with myosin II motors, mediate ER-to-Golgi trafficking.

Keywords: actin cytoskeleton; membrane trafficking; myosin; tropomyosin.

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / genetics
  • Actin Cytoskeleton / metabolism*
  • Actins / genetics
  • Actins / metabolism
  • Animals
  • Brefeldin A / pharmacology
  • Cell Movement / genetics
  • Cell Movement / physiology
  • Cells, Cultured
  • Cytoskeletal Proteins / metabolism
  • Cytoskeleton / drug effects
  • Cytoskeleton / metabolism
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / genetics
  • Endoplasmic Reticulum / metabolism*
  • Fibroblasts / metabolism
  • Golgi Apparatus / drug effects
  • Golgi Apparatus / genetics
  • Golgi Apparatus / metabolism*
  • Humans
  • Mice
  • Myosin Type II / metabolism*
  • Protein Transport / drug effects
  • Protein Transport / genetics
  • Tropomyosin / genetics
  • Tropomyosin / metabolism*

Substances

  • Actins
  • Cytoskeletal Proteins
  • TPM4 protein, human
  • Tropomyosin
  • Brefeldin A
  • Myosin Type II